UK markets close in 3 hours 28 minutes

Novartis AG (0QLR.IL)

IOB - IOB Delayed price. Currency in CHF
Add to watchlist
74.00+0.75 (+1.02%)
As of 12:28PM GMT. Market open.
Full screen
Previous close73.25
Bid72.00 x N/A
Ask75.50 x N/A
Day's range73.50 - 74.15
52-week range24.00 - 308.00
Avg. volume1,011,182
Market cap167.782B
Beta (5Y monthly)0.53
PE ratio (TTM)18.52
EPS (TTM)4.00
Earnings dateN/A
Forward dividend & yield3.00 (4.04%)
Ex-dividend date04 Mar 2021
1y target estN/A
  • Reuters

    Novartis chairman says all options open for Sandoz unit - report

    Novartis is keeping all options open for the future of its generics division Sandoz, its chairman said in an interview with Swiss TV channel TeleZüri to be broadcast on Tuesday. Asked whether Novartis could merge Sandoz with either Israel's Teva or U.S.-based Viatris or divest it, Joerg Reinhardt said: "All options are open for us." Reinhardt said Novartis's innovative pharma business and the generics business had drifted further apart over the last years so it made sense to examine options now.

  • Zacks

    Deciphera (DCPH) Down More Than 70% in Past 3 Months: Here's Why

    Deciphera's (DCPH) sole marketed drug, Qinlock, is approved for treating advanced gastrointestinal stromal tumors. The recent regulatory setback for Qinlock has hurt the stock.

  • Reuters

    Roche shareholders approve deal to buy Novartis's $20.7 billion stake

    Roche shareholders voted overwhelmingly on Friday to support the $20.7 billion deal to buy Novartis's nearly one third voting stake, the Swiss drugmaker said. Roche held an extraordinary general meeting to settle matters related to its plan to disentangle the two pharma companies, both based in Basel, who had been linked by the investment for two decades. Shareholders approved the audited statutory interim financial statements of the company as of 31 October 2021 with a majority of 100.00%, Roche said.